Clinical Trial

Diaplex and Glycemic Control

Name: Diaplex and Glycemic Control — clinical trial record (NCT07711587)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this 16-week double-blind, placebo-controlled pilot study is to determine whether daily Diaplex supplementation improves insulin sensitivity and glycemic control in adults with elevated blood glucose levels, while generating high-quality preliminary data on metabolic effects, glycemic patterns, and safety to inform future trials

Trial Details

NCT Number	NCT07711587
Lead Sponsor	Standard Process Inc.
Conditions	Insulin Sensitivity, Healthy Adult
Enrollment	40 participants
Start Date	2026-09-01
Primary Completion	2027-10-30 (estimated)
Study Completion	2027-12-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-17